Pitney Bowes Inc. (PBI) Touches $11.32 Formed H&S; GETINGE AB ORDINARY SHARES B SWEDEN (GNGBF) Shorts Lowered By 5.81%

Pitney Bowes Inc. (PBI) formed inverse H&S with $12.00 target or 6.00% above today’s $11.32 share price. Pitney Bowes Inc. (PBI) has $2.11B valuation. The stock decreased 4.39% or $0.52 during the last trading session, reaching $11.32. About 1.27M shares traded. Pitney Bowes Inc. (NYSE:PBI) has declined 15.45% since March 25, 2017 and is downtrending. It has underperformed by 32.15% the S&P500.

GETINGE AB ORDINARY SHARES B SWEDEN (OTCMKTS:GNGBF) had a decrease of 5.81% in short interest. GNGBF’s SI was 1.29 million shares in March as released by FINRA. Its down 5.81% from 1.37M shares previously. With 100 avg volume, 12866 days are for GETINGE AB ORDINARY SHARES B SWEDEN (OTCMKTS:GNGBF)’s short sellers to cover GNGBF’s short positions. The SI to GETINGE AB ORDINARY SHARES B SWEDEN’s float is 0.57%. It closed at $12.52 lastly. It is down 0.00% since March 25, 2017 and is . It has underperformed by 16.70% the S&P500.

Getinge AB provides products and services for surgery, intensive-care, long-term care, infection control, and sterilization in Sweden and internationally. The company has market cap of $3.10 billion. The firm operates through Acute Care Therapies, Patient & Post-Acute Care, and Surgical Workflows divisions. It has a 18.69 P/E ratio. It offers infection control systems for hospitals under the Getinge and Maquet brands; equipment for complete surgical workplaces and expanded treatment options; equipment, consumables, and services for cleaning, disinfection and sterilization of instruments; and IT tracking systems.

Analysts await Pitney Bowes Inc. (NYSE:PBI) to report earnings on May, 1. They expect $0.29 earnings per share, down 19.44% or $0.07 from last year’s $0.36 per share. PBI’s profit will be $54.16M for 9.76 P/E if the $0.29 EPS becomes a reality. After $0.40 actual earnings per share reported by Pitney Bowes Inc. for the previous quarter, Wall Street now forecasts -27.50% negative EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: